Health Services Research & Development

• Wang Z, White DL, Hoogeveen R, Chen L, Whitsel EA, Richardson PA, Virani SS, Garcia JM, El-Serag HB, Jiao L. Anti-Hypertensive Medication Use, Soluble Receptor for Glycation End Products and Risk of Pancreatic Cancer in the Women's Health Initiative Study. Journal of clinical medicine. 2018 Aug 2; 7(8).
• Becker DJ, Levy BP, Gold HT, Sherman SE, Makarov DV, Schreiber D, Wisnivesky JP, Pass HI. Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer. American Journal of Clinical Oncology : The Official Publication of The American Radium Society. 2018 Aug 1; 41(8):820-825.
• Dong J, Gu X, El-Serag HB, Thrift AP. Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018 Jul 20.
• Chang E, Sabichi AL, Kramer JR, Hartman C, Royse KE, White DL, Patel NR, Richardson P, Yellapragada SV, Garcia JM, Chiao EY. Nivolumab Treatment for Cancers in the HIV-infected Population. Journal of immunotherapy (Hagerstown, Md. : 1997). 2018 Jul 16.
• Chai CY, Tran Cao HS, Massarweh NN. Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes-Reply. JAMA surgery. 2018 Jul 1; 153(7):691-692.

» View more Citations

• Increase in Conservative Management of Veterans with Low-Risk Prostate Cancer Suggests Reduction in Over-Treatment
  Investigators assessed utilization of conservative management among Veterans by examining treatment patterns for Veterans diagnosed with low-risk prostate cancer. Untreated Veterans were classified as receiving conservative management through either active surveillance (> 2 PSAs and 1 biopsy within 2 years after diagnosis) or watchful waiting. Findings showed that utilization of conservative manag...
  
  Date: June 5, 2018
• VA’s Lower Intensity Treatment of Kidney Failure – Compared to Medicare – Does Not Result in Associated Increased Mortality
  This study compared the initiation of dialysis and mortality among Veterans ages 67 and older with incident kidney failure who received pre-end-stage renal disease (ESRD) care in fee-for-service Medicare vs. VA between January 2008 and December 2011. Findings showed that Veterans who received pre-ESRD nephrology care in Medicare received dialysis more often than Veterans who received VA care (82% ...
  
  Date: April 9, 2018
• Evidence Review Identifies Modest Mortality Disparities among Racial and Ethnic Minority Groups in VA Healthcare
  To support VA’s efforts to better understand the scale and determinants of disparities in racial and ethnic mortality – and to develop interventions to reduce disparities, investigators from the VA Evidence-based Synthesis Program (ESP) Coordinating Center in Portland, OR conducted an evidence review of mortality disparities specific to VA. Findings showed that although VA’s equal access healthcar...
  
  Date: March 1, 2018
• Veterans with Cancer Received Higher Quality, Lower Intensity End-of Life Care in VA Compared to Medicare
  This study evaluated the quality of end-of-life cancer care provided by Fee-for-Service (FFS) Medicare and VA, using well-accepted quality-of-care metrics. Findings showed that Veterans treated under FFS Medicare were more likely to get unduly intensive healthcare at end-of-life compared to those treated by VA. For example, Medicare-reliant Veterans were significantly more likely to receive chemot...
  
  Date: January 1, 2018
• HCV-Related Complications Increasing among Women Veterans
  This study examined gender-related differences in the incidence and prevalence of cirrhosis, decompensated cirrhosis, and hepatocellular cancer (HCC) between 2000 and 2013. Findings showed that the incidence and prevalence of hepatitis C virus (HCV) complications was higher in men than in women. However, the rate of increase in the incidence rates of cirrhosis and decompensated cirrhosis among HCV...
  
  Date: November 1, 2017

» View more Publication Briefs

» View more Studies

• Management Briefs eBrief-no63 - Treatment of Metastatic Non-Small Cell Lung Cancer
  ...and Cost-Effectiveness: Treatment of Metastatic Non-Small Cell Lung Cancer Most patients with lung cancer are diagnosed when the cancer is already...
  
  
• Management Briefs eBrief-no70 - Effects of Caregiver Interventions on Outcomes for Memory-related Disorders or Cancer
  ...Management Briefs eBrief-no70 Effects of Caregiver Interventions on Outcomes for Memory-related Disorders or Cancer Management Brief no. 70...
  
  
• Management Briefs eBrief-no87 - A Systematic Review: Shared Decision Making for Cancer Screening
  ...Management Briefs Issue 87 October 2014 A Systematic Review: Shared Decision Making for Cancer Screening Patient decisions about cancer screening...
  
  
• The Effects of Shared Decision Making on Cancer Screening
  ...Most organizations publishing clinical practice guidelines for cancer screening now recommend that preference-sensitive cancer screening decisions...
  
  
• Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness
  ...and more effective treatments. Most patients with lung cancer are diagnosed when the cancer is already advanced (stage IIIB or IV), and they are...
  
  

» View more Publications

» View more Cyberseminars

Videos

There are currently no videos for this topic.

Podcasts

There are currently no podcasts for this topic.

Other Resources

• Visit the HSR&D Center for Chronic Disease Outcomes Research and learn more about their research focus on cancer prevention and screening.
• Learn more about how to volunteer in VA-funded research studies.
• Access the Veterans Health Library to find out more information about cancer or other health conditions.